Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis
- 1 August 1991
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 101 (2) , 497-502
- https://doi.org/10.1016/0016-5085(91)90030-o
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Survival in cirrhosis: Importance of age as an indicator of disease durationJournal of Hepatology, 1989
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- ALPHA-INTERFERON THERAPY FOR NON-A, NON-B HEPATITIS TRANSMITTED BY GAMMAGLOBULIN REPLACEMENT THERAPYThe Lancet, 1987
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot studyJournal of Medical Virology, 1985
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981